Jiangsu Hengrui Pharmaceuticals (01276) repurchased 150,000 A shares on October 22 for approximately RMB 6.9152 million.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on October 22, 2026, it repurchased 150,000 A shares for approximately RMB 6.9152 million.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on October 22, 2026, it repurchased 150,000 A shares for approximately RMB 6.9152 million.
Related Articles
ALPHAMAB-B (09966) repurchased 145,000 shares for HK$940,100 on October 22.
AOM INT'L (00381) Subsidiary Plans to Establish Yingyang Intelligent Technology Co., Ltd. with Joint Venture Partner to Build a Global Health Data Asset Operations Platform
The Procter & Gamble Company (PG.US) Q1 results beat expectations across the board: organic sales grew 4%, and a rebound in volume reversed the growth structure.
ALPHAMAB-B (09966) repurchased 145,000 shares for HK$940,100 on October 22.
AOM INT'L (00381) Subsidiary Plans to Establish Yingyang Intelligent Technology Co., Ltd. with Joint Venture Partner to Build a Global Health Data Asset Operations Platform
The Procter & Gamble Company (PG.US) Q1 results beat expectations across the board: organic sales grew 4%, and a rebound in volume reversed the growth structure.
